BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32300340)

  • 1. Large-Scale Generation of Human Allospecific Induced Tregs With Functional Stability for Use in Immunotherapy in Transplantation.
    Alvarez-Salazar EK; Cortés-Hernández A; Arteaga-Cruz S; Alberú-Gómez J; Soldevila G
    Front Immunol; 2020; 11():375. PubMed ID: 32300340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.
    Cortés-Hernández A; Alvarez-Salazar EK; Arteaga-Cruz S; Rosas-Cortina K; Linares N; Alberú Gómez JM; Soldevila G
    Front Immunol; 2021; 12():686530. PubMed ID: 34777330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of allo-antigen-specific induced Treg stabilized by vitamin C treatment and its application for prevention of acute graft versus host disease model.
    Kasahara H; Kondo T; Nakatsukasa H; Chikuma S; Ito M; Ando M; Kurebayashi Y; Sekiya T; Yamada T; Okamoto S; Yoshimura A
    Int Immunol; 2017 Dec; 29(10):457-469. PubMed ID: 29126272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
    Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J
    PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of CD4
    Khosravi M; Bidmeshkipour A; Cohen JL; Moravej A; Hojjat-Assari S; Naserian S; Karimi MH
    Stem Cell Res Ther; 2018 Oct; 9(1):273. PubMed ID: 30359308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.
    Brennan TV; Tang Q; Liu FC; Hoang V; Bi M; Bluestone JA; Kang SM
    J Surg Res; 2011 Jul; 169(1):e69-75. PubMed ID: 21571317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
    Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
    Hum Immunol; 2012 Nov; 73(11):1061-7. PubMed ID: 22939904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and
    Hui Z; Zhang J; Zheng Y; Yang L; Yu W; An Y; Wei F; Ren X
    Front Immunol; 2021; 12():619932. PubMed ID: 33868236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.
    Pothoven KL; Kheradmand T; Yang Q; Houlihan JL; Zhang H; Degutes M; Miller SD; Luo X
    Am J Transplant; 2010 Aug; 10(8):1774-84. PubMed ID: 20626386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly purified and functionally stable
    Arteaga-Cruz S; Cortés-Hernández A; Alvarez-Salazar EK; Rosas-Cortina K; Aguilera-Sandoval C; Morales-Buenrostro LE; Alberú-Gómez JM; Soldevila G
    Front Immunol; 2023; 14():1062456. PubMed ID: 36911743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
    Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
    Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
    Schmidt A; Éliás S; Joshi RN; Tegnér J
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
    Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
    J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25
    Wilkinson DS; Ghosh D; Nickle RA; Moorman CD; Mannie MD
    Front Immunol; 2017; 8():1782. PubMed ID: 29312311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural and inducible Tregs in swine: Helios expression and functional properties.
    Käser T; Mair KH; Hammer SE; Gerner W; Saalmüller A
    Dev Comp Immunol; 2015 Apr; 49(2):323-31. PubMed ID: 25511662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
    Jiang S; Tsang J; Lechler RI
    Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro Conversion into CD4+CD25+Foxp3+ Induced Regulatory T Cells Is Reduced in Atopic Dermatitis Patients.
    García EM; Galicia-Carreón J; Novak N
    Int Arch Allergy Immunol; 2020; 181(5):353-356. PubMed ID: 32160611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The suppressive function of human CD8(+) iTregs is inhibited by IL-1β and TNFα.
    Bjarnadottir U; Lemarquis AL; Halldorsdottir S; Freysdottir J; Ludviksson BR
    Scand J Immunol; 2014 Nov; 80(5):313-22. PubMed ID: 25039313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.